Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SEC14-like protein 3 (SEC14L3) is a multi-domain lipid transfer protein containing SEC14, GOLD, CARL-TRIO, and GTPase domains, and is part of a conserved protein family across eukaryotes responsible for controlling membrane identity and trafficking via lipid binding, exchange, and interaction with key signaling pathways[2][1][3]. SEC14L3 directly interacts with Wnt signaling components, such as Frizzled (Fz), Dishevelled (Dvl), and phospholipase C, to regulate calcium signaling and PLCδ activation in response to external cues like Wnt5a[1][3]. Both its lipid transfer and GTPase functions are essential for proper cellular signaling and developmental processes. SEC14-like proteins are implicated in cancer and neurodegenerative disease risk, likely due to their role in oxidative stress response and the maintenance of membrane integrity and signaling[2]. SEC14L3 may function as a tumor suppressor by mediating the transport of vitamin E (tocopherol) and other lipophilic substances, highlighting interconnected roles in lipid metabolism, cellular signaling, and homeostasis[2]. While no approved drugs currently target SEC14L3, its role in fundamental cellular processes makes it a potential therapeutic target pending further study[2][1][3].
Not established for approved drugs. Possible mechanisms may involve regulation of membrane phospholipid composition, modulation of PLC signaling, or control of calcium flux via PLC activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SEC14-like protein 3 (SEC14L3).